Colonization of long term care facility patients with MDR-Gram-negatives during an Acinetobacter baumannii outbreak

Antimicrobial Resistance and Infection Control
Ines Zollner-SchwetzEva Leitner

Abstract

We aimed to determine the prevalence of colonization by multidrug-resistant Gram-negative bacteria including ESBL-producing enterobacteriaceae, carbapenem-resistant enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii at two wards caring long term for patients with disorder of consciousness at the Geriatric Health Centers Graz, Austria. During our study we detected two A. baumannii outbreaks. In August 2015, we conducted a point-prevalence study. Inguinal and perianal swabs were taken from 38 patients and screened for multidrug-resistant Gram-negative rods using standard procedures. Six months after the initial investigation all patients were sampled again and use of antibiotics during the past 6 months and mortality was registered. Genetic relatedness of bacteria was evaluated by DiversiLab system. Fifty percent of patients were colonized by multidrug-resistant Gram-negative isolates. Five patients harboured ESBL-producing enterobacteriaceae. No carbapenem-resistant enterobacteriaceae were detected. 13/38 patients were colonized by A. baumannii isolates (resistant to ciprofloxacin but susceptible to carbapenems). There was a significant difference in the prevalence of colonization by A. baumannii between ward...Continue Reading

References

Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P ReddyT Zembower
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter J SebenyKyle Petersen
Sep 13, 2008·American Journal of Infection Control·Jon P FurunoAnthony D Harris
Mar 31, 2009·Future Microbiology·Jennifer A Gaddy, Luis A Actis
Aug 19, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A MarchN Woodford
May 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M SengstockK S Kaye
Sep 25, 2012·American Journal of Infection Control·Gabriel BirgandJean-Christophe Lucet
Mar 8, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Hélène CochardUNKNOWN Réseau des Hygiénistes du Centre
Mar 8, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Eva MortensenDuc J Vugia

❮ Previous
Next ❯

Citations

Jul 25, 2018·Antimicrobial Resistance and Infection Control·Philipp KohlerAndreas Kronenberg
Jan 12, 2021·Aging Clinical and Experimental Research·M TinelliUNKNOWN ESCMID Study Group for Infections in the Elderly
Feb 17, 2021·Indian Journal of Medical Microbiology·Manisha BiswalRimjhim Kanaujia
Apr 10, 2021·Antimicrobial Resistance and Infection Control·Marianna MeschiariCristina Mussini
Jul 24, 2021·Journal of the American Medical Directors Association·Philipp KohlerDelphine Héquet

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

DiversiLab
SPSS

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Anthony D HarrisJon P Furuno
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Eva MortensenDuc J Vugia
© 2022 Meta ULC. All rights reserved